Expertise in
7
conditions

Dr. Sandra M. Swain

Oncology
Office
4000 Reservoir Rd NW, 
Washington, DC 
Expertise in
7
conditions
Office
4000 Reservoir Rd NW, 
Washington, DC 

Overview

Sandra Swain is an Oncologist practicing medicine in Washington, Washington, D.c..

Dr. Swain is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, PIK3CA-Related Overgrowth Spectrum, and HER-2 Positive Breast Cancer.

She is actively involved in clinical research, co-authoring 173 peer reviewed articles and participating in 3 clinical trials.

Specialties

Oncology

Licenses

Internal Medicine in MD

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Office
4000 Reservoir Rd NW, Washington, DC 20007
Other Locations
MedStar Georgetown University Hospital
3800 Reservoir Rd NW, Washington, DC 20007

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

evaLuation of Variations pharmacokinEtics and phArmacogeNOmics of Ribociclib in rAce-based Cohorts: The LEANORA Study
evaLuation of Variations pharmacokinEtics and phArmacogeNOmics of Ribociclib in rAce-based Cohorts: The LEANORA Study
Enrollment Status: Terminated
Publish Date: November 26, 2024
Intervention Type: Drug
Study Phase: Phase 4
Diarrhea Prevention and Prophylaxis With Crofelemer in HER2 Positive Breast Cancer Patients Receiving Trastuzumab, Pertuzumab, and Docetaxel or Paclitaxel With or Without Carboplatin: HALT-D
Diarrhea Prevention and Prophylaxis With Crofelemer in HER2 Positive Breast Cancer Patients Receiving Trastuzumab, Pertuzumab, and Docetaxel or Paclitaxel With or Without Carboplatin: HALT-D
Enrollment Status: Completed
Publish Date: October 24, 2022
Intervention Type: Drug
Study Drug: Crofelemer
Study Phase: Phase 2
SAFE-HEaRt: A Pilot Study Assessing the Cardiac SAFEty of HER2 Targeted Therapy in Patients With HER2 Positive Breast Cancer and Reduced Left Ventricular Function
SAFE-HEaRt: A Pilot Study Assessing the Cardiac SAFEty of HER2 Targeted Therapy in Patients With HER2 Positive Breast Cancer and Reduced Left Ventricular Function
Enrollment Status: Completed
Publish Date: May 10, 2022
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

173 Total Publications

Sex-based prognosis in industry-sponsored advanced solid tumor trials: an individual participant data meta-analysis of survival and adverse events.
Sex-based prognosis in industry-sponsored advanced solid tumor trials: an individual participant data meta-analysis of survival and adverse events.
Journal: Journal of the National Cancer Institute
Published: November 26, 2025
Similar Doctors
Expertise in
17
conditions
Expertise in
17
conditions
Referral may be required

MedStar Georgetown University Hospital

3800 Reservoir Rd NW, 
Washington, DC 
 (0.2 miles away)
202-444-2000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Bruce Cheson is an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Cheson is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Follicular Lymphoma, Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), and Non-Hodgkin Lymphoma. Dr. Cheson is currently accepting new patients.

Expertise in
19
conditions
Dr. Brigitte C. Widemann
Hematology | Oncology
Expertise in
19
conditions
Dr. Brigitte C. Widemann
Hematology | Oncology
Referral may be required

Office

8906 Bradmoor Dr, 
Bethesda, MD 
 (6.6 miles away)
301-496-7387
Languages Spoken:
English

Brigitte Widemann is a Hematologist and an Oncologist practicing medicine in Bethesda, Maryland. Dr. Widemann is highly rated in 19 conditions, according to our data. Her clinical expertise encompasses Neurofibromatosis, Malignant Peripheral Nerve Sheath Tumor, Fibrosarcoma, Medullary Thyroid Carcinoma, and Thyroidectomy.

Expertise in
12
conditions
Dr. David H. Vesole
Oncology | Hematology
Expertise in
12
conditions
Dr. David H. Vesole
Oncology | Hematology
Referral may be required
Before you request

MedStar Georgetown University Hospital

3800 Reservoir Road Northwest, 
Washington, DC 
 (0.1 miles away)
551-996-8704
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

David Vesole is an Oncologist and a Hematologist practicing medicine in Washington, Washington, D.c.. Dr. Vesole is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Bone Marrow Transplant. Dr. Vesole is board certified in American Board Of Internal Medicine. Dr. Vesole is currently accepting new patients.

Frequently Asked Questions about Dr. Sandra M. Swain

How do I make an appointment with Dr. Sandra M. Swain?

You can book an appointment with Dr. Sandra M. Swain by calling their office at 202-687-8487. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Sandra M. Swain a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Sandra M. Swain is classified as an Elite expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Sandra M. Swain specialize in?

While Dr. Sandra M. Swain is a Oncology, they have specific expertise in Breast Cancer, Inflammatory Breast Cancer, and PIK3CA-Related Overgrowth Spectrum. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Sandra M. Swain participate in research or clinical trials?

Yes. Dr. Sandra M. Swain has published 173 articles and abstracts on conditions like Breast Cancer. You can view a list of Dr. Sandra M. Swain's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Swain's expertise for a condition
ConditionClose
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile